These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8605811)

  • 21. Prophylaxis for stress-related gastric hemorrhage.
    Martin JN
    Ann Intern Med; 1995 Apr; 122(8):633; author reply 633-4. PubMed ID: 7887568
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impacting cost and appropriateness of stress ulcer prophylaxis at a university medical center.
    Erstad BL; Camamo JM; Miller MJ; Webber AM; Fortune J
    Crit Care Med; 1997 Oct; 25(10):1678-84. PubMed ID: 9377882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy insight: Prophylaxis of stress-induced gastrointestinal bleeding in critically ill patients.
    Klebl FH; Schölmerich J
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):562-70. PubMed ID: 17909533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of antacid and sucralfate in the prevention of gastrointestinal bleeding in patients who are critically ill.
    Borrero E; Bank S; Margolis I; Schulman ND; Chardavoyne R
    Am J Med; 1985 Aug; 79(2C):62-4. PubMed ID: 3898835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of misoprostol for prophylaxis against nonsteroidal anti-inflammatory drug-induced gastrointestinal tract bleeding.
    Edelson JT; Tosteson AN; Sax P
    JAMA; 1990 Jul; 264(1):41-7. PubMed ID: 2113103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National survey of stress ulcer prophylaxis.
    Lam NP; Lê PD; Crawford SY; Patel S
    Crit Care Med; 1999 Jan; 27(1):98-103. PubMed ID: 9934901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized controlled trial.
    Prod'hom G; Leuenberger P; Koerfer J; Blum A; Chiolero R; Schaller MD; Perret C; Spinnler O; Blondel J; Siegrist H; Saghafi L; Blanc D; Francioli P
    Ann Intern Med; 1994 Apr; 120(8):653-62. PubMed ID: 8135449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current guidelines on stress ulcer prophylaxis.
    Tryba M; Cook D
    Drugs; 1997 Oct; 54(4):581-96. PubMed ID: 9339962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage.
    Misra UK; Kalita J; Pandey S; Mandal SK; Srivastava M
    J Neurol Sci; 2005 Dec; 239(1):5-10. PubMed ID: 16182311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness analysis: stress ulcer bleeding prophylaxis with proton pump inhibitors, H2 receptor antagonists.
    Barkun AN; Adam V; Martel M; Bardou M
    Value Health; 2013; 16(1):14-22. PubMed ID: 23337211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of stress bleeding--do we need a new concept?].
    Tryba M
    Dtsch Med Wochenschr; 1986 Oct; 111(43):1627-9. PubMed ID: 2876875
    [No Abstract]   [Full Text] [Related]  

  • 33. Stress ulcer prophylaxis with a proton pump inhibitor versus placebo in critically ill patients (SUP-ICU trial): study protocol for a randomised controlled trial.
    Krag M; Perner A; Wetterslev J; Wise MP; Borthwick M; Bendel S; Pelosi P; Keus F; Guttormsen AB; Schefold JC; Møller MH;
    Trials; 2016 Apr; 17(1):205. PubMed ID: 27093939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylaxis of stress ulcer bleeding. A meta-analysis.
    Tryba M
    J Clin Gastroenterol; 1991; 13 Suppl 2():S44-55. PubMed ID: 1832181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress ulcer prophylaxis: gastrointestinal bleeding and nosocomial pneumonia. Best evidence synthesis.
    Cook DJ
    Scand J Gastroenterol Suppl; 1995; 210():48-52. PubMed ID: 8578207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of trauma stress ulcer prophylaxis guidelines on drug cost and frequency of major gastrointestinal bleeding.
    Devlin JW; Claire KS; Dulchavsky SA; Tyburski JG
    Pharmacotherapy; 1999 Apr; 19(4):452-60. PubMed ID: 10212018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stress-ulcer prophylaxis for general medical patients: a review of the evidence.
    Janicki T; Stewart S
    J Hosp Med; 2007 Mar; 2(2):86-92. PubMed ID: 17427249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine.
    Thomason MH; Payseur ES; Hakenewerth AM; Norton HJ; Mehta B; Reeves TR; Moore-Swartz MW; Robbins PI
    J Trauma; 1996 Sep; 41(3):503-8. PubMed ID: 8810971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sucralfate suspension versus titrated antacid for the prevention of acute stress-related gastrointestinal hemorrhage in critically ill patients.
    Bresalier RS; Grendell JH; Cello JP; Meyer AA
    Am J Med; 1987 Sep; 83(3B):110-6. PubMed ID: 3499074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of histamine receptor-2 antagonist versus proton pump inhibitor for stress ulcer prophylaxis in critically ill patients*.
    MacLaren R; Campbell J
    Crit Care Med; 2014 Apr; 42(4):809-15. PubMed ID: 24365863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.